<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">ZLG3hWCPdZ47DTPZZMRykbk</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2020000300493</article-id>
      <article-id pub-id-type="publisher-id">abc.20200068</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20200068</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Minieditorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Exerc&#237;cio F&#237;sico e Teste de Caminhada de 6-min na Doen&#231;a Arterial Obstrutiva de Membros Inferiores</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-8817-1255</contrib-id>
          <name>
            <surname>Carvalho</surname>
            <given-names>Tales de</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Cl&#237;nica de Preven&#231;&#227;o e Reabilita&#231;&#227;o Cardiosport</institution>
        <addr-line>
          <named-content content-type="city">Florian&#243;polis</named-content>
          <named-content content-type="state">SC</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Cl&#237;nica de Preven&#231;&#227;o e Reabilita&#231;&#227;o Cardiosport, Florian&#243;polis, SC &#8211; Brasil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Universidade do Estado de Santa Catarina</institution>
        <addr-line>
          <named-content content-type="city">Florian&#243;polis</named-content>
          <named-content content-type="state">SC</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Universidade do Estado de Santa Catarina (UDESC-SC), Florian&#243;polis, SC &#8211; Brasil</institution>
      </aff>
      <author-notes>
        <corresp id="c01"> Correspond&#234;ncia: Tales de Carvalho &#8226; Avenida Jornalista Rubens de Arruda Ramos, 2354, apto 201. CEP: 88015-705, Florian&#243;polis, SC &#8211; Brasil E-mail: <email>tales@cardiol.br</email>, <email>talescarvalho@icloud.com</email>
				</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>06</day>
        <month>04</month>
        <year>2020</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <season>May-Jun</season>
        <year>2020</year>
      </pub-date>
      <volume>114</volume>
      <issue>3</issue>
      <fpage>493</fpage>
      <lpage>495</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="pt">
        <kwd>Doen&#231;a Arterial Perif&#233;rica</kwd>
        <kwd>Claudica&#231;&#227;o Intermitente</kwd>
        <kwd>Limiar Anaer&#243;bio</kwd>
        <kwd>Exerc&#237;cio</kwd>
        <kwd>Teste de Caminhada</kwd>
        <kwd>Atividades F&#237;sicas da Vida Di&#225;ria</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="15"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>O artigo &#8220;Intensidade de Exerc&#237;cio durante o Teste de Caminhada de 6 Minutos em Pacientes com Doen&#231;a Arterial Perif&#233;rica&#8221;,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> com originalidade, produz informa&#231;&#245;es de grande utilidade pr&#225;tica, a serem consideradas no diagn&#243;stico, progn&#243;stico e principalmente na avalia&#231;&#227;o funcional, que possibilitam um aprimoramento da prescri&#231;&#227;o de exerc&#237;cios f&#237;sicos no tratamento cl&#237;nico da doen&#231;a. O estudo foi realizado com o objetivo de determinar em pacientes sintom&#225;ticos com Doen&#231;a Arterial Obstrutiva (DAO) de Membros Inferiores (MMII) se a caminhada no solo permite a detec&#231;&#227;o do primeiro limiar ventilat&#243;rio, tamb&#233;m denominado limiar anaer&#243;bio (LA). O LA &#233; um marcador reconhecido de intensidade do exerc&#237;cio, &#250;til para a delimita&#231;&#227;o da zona considerada ideal para o treinamento f&#237;sico visando o aprimoramento cardiorrespirat&#243;rio.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
    <p>A DAO de MMII &#233; um grande problema de sa&#250;de p&#250;blica, que de acordo com o relat&#243;rio global de epidemiologia, acometia 202 milh&#245;es de indiv&#237;duos em 2010, crescendo 22% at&#233; 2015, quando atingiu 237 milh&#245;es de indiv&#237;duos.<sup><xref ref-type="bibr" rid="B3">3</xref></sup>A associa&#231;&#227;o da DAO com grandes eventos cardiovasculares (MACE) est&#225; bem documentada; em seu est&#225;gio mais grave, com isquemia cr&#237;tica, apresenta elevado risco de eventos cardiovasculares, amputa&#231;&#227;o de MMII e morte,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> associando-se a n&#237;veis elevados de troponina card&#237;aca e pept&#237;deo natriur&#233;tico cerebral pro-N-terminal (NT proBNP).<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
    <p>H&#225; forte suspeita de DAO de MMII quando ocorre dor em MMII ao esfor&#231;o sem aparente etiologia ortop&#233;dica e o &#237;ndice tornozelo-braquial (ITB) &#233; menor que 0,90 em repouso. Os testes de esfor&#231;o realizados com caminhadas devem ser realizados para auxiliar no diagn&#243;stico, especialmente quando o ITB for maior que 0,91, sendo &#250;teis tamb&#233;m para classifica&#231;&#227;o funcional e prescri&#231;&#227;o de exerc&#237;cios.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Os testes de campo possibilitam o diagn&#243;stico de claudica&#231;&#227;o intermitente, com determina&#231;&#227;o das dist&#226;ncias percorridas para o in&#237;cio da sintomatologia (claudica&#231;&#227;o inicial) e para o surgimento da m&#225;xima limita&#231;&#227;o funcional (claudica&#231;&#227;o absoluta), quando o indiv&#237;duo &#233; obrigado a interromper a caminhada. Nos testes em esteira tem sido proposta a inclus&#227;o da medida do ITB em repouso e ap&#243;s exerc&#237;cio. A presen&#231;a da doen&#231;a &#233; fortemente sugerida quando ocorre redu&#231;&#227;o do ITB p&#243;s-exerc&#237;cio superior a 20% e a 30mmHg em rela&#231;&#227;o ao observado ao repouso.<sup><xref ref-type="bibr" rid="B7">7</xref></sup> O ITB em repouso, que tem sido amplamente utilizado na pr&#225;tica cl&#237;nica, pode com certa frequ&#234;ncia produzir um resultado falso negativo, exigindo aten&#231;&#227;o a grupos com art&#233;rias n&#227;o compress&#237;veis. No estudo de T&#243;th-Vajna et al.,<sup><xref ref-type="bibr" rid="B8">8</xref></sup> quase um quarto dos indiv&#237;duos com diagn&#243;stico apresentou art&#233;ria n&#227;o compress&#237;vel ou foi considerado sintom&#225;tico com ITB negativo. Portanto, se houver suspeita cl&#237;nica de DAO dos MMII, apesar dos valores normais do ITB, uma avalia&#231;&#227;o mais aprofundada deve ser considerada.</p>
    <p>Em pacientes sintom&#225;ticos os exerc&#237;cios f&#237;sicos t&#234;m potencial para influir na morbidade e mortalidade, proporcionando redu&#231;&#227;o dos sintomas, melhora da qualidade de vida e aumento da dist&#226;ncia m&#225;xima caminhada, devendo obrigatoriamente integrar o tratamento otimizado.<sup><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref></sup>Portanto, todos os pacientes com claudica&#231;&#227;o intermitente devem receber tratamento cl&#237;nico otimizado, ou seja, uma associa&#231;&#227;o de mudan&#231;as de estilo de vida com tratamento farmacol&#243;gico, tendo em vista as evid&#234;ncias que demonstram redu&#231;&#227;o de eventos cardiovasculares e melhora de desfechos relacionados aos MMII.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
    <p>O treinamento f&#237;sico tem se mostrado seguro, sendo os exerc&#237;cios realizados por meio de caminhadas com indu&#231;&#227;o do sintoma de claudica&#231;&#227;o a melhor op&#231;&#227;o.<sup><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref></sup> Mas, quando a caminhada n&#227;o puder ser realizada, outros tipos de exerc&#237;cios, como ciclismo, exerc&#237;cios resistidos e erg&#244;metro de membros superiores, t&#234;m se mostrado efetivos.<sup><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref></sup> Cabe ainda ressaltar que exerc&#237;cios f&#237;sicos n&#227;o podem ser realizados por pacientes com isquemia cr&#237;tica, mas devem ser considerados o mais breve poss&#237;vel ap&#243;s tratamento intervencionista realizado com sucesso.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref></sup></p>
    <p>Muitos ensaios cl&#237;nicos demonstraram consistentemente que o exerc&#237;cio supervisionado em esteira melhora o desempenho da marcha em pessoas com DAO de MMII. A metan&#225;lise de Fakhry et al.,<sup><xref ref-type="bibr" rid="B12">12</xref></sup> que avaliou 1054 indiv&#237;duos em 25 estudos, concluiu que esse tipo de exerc&#237;cio proporcionou em m&#233;dia aumento de 180 metros na dist&#226;ncia m&#225;xima de caminhada na esteira e de 128 metros na dist&#226;ncia caminhada sem dor.<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
    <p>Tr&#234;s ensaios cl&#237;nicos randomizados, que avaliaram um total de 493 pacientes com DAO de MMII, demonstraram que as interven&#231;&#245;es com exerc&#237;cios baseados em domic&#237;lio, que incorporaram t&#233;cnicas de mudan&#231;a comportamental, aumentaram a capacidade para caminhar, sendo superiores em proporcionar ganho no desempenho no teste de caminhada de seis minutos na compara&#231;&#227;o com os exerc&#237;cios supervisionados realizados em esteira.<sup><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup> Ou seja, enquanto programas de exerc&#237;cios supervisionados em esteira s&#227;o superiores em aumentar o desempenho da caminhada na esteira, os programas de exerc&#237;cios baseados em domic&#237;lio s&#227;o superiores para melhorar o desempenho em caminhada no solo, algo mais bem relacionado &#224;s atividades da vida di&#225;ria<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
    <p>Embora em estudos mais recentes os exerc&#237;cios de caminhada no solo baseados em domic&#237;lio tenham se mostrado mais eficazes para o desempenho nas atividades da vida di&#225;ria, sendo mais indicados do que os exerc&#237;cios supervisionados em esteira,<sup><xref ref-type="bibr" rid="B14">14</xref></sup> os pequenos estudos iniciais mostraram pouco ou nenhum benef&#237;cio, justificando que nas Diretrizes de Pr&#225;tica Cl&#237;nica do <italic>American College of Cardiology/American Heart Association</italic> de 2006 constasse equivocadamente &#8220;n&#227;o haver evid&#234;ncias para aconselhar os pacientes a irem para casa caminhar&#8221;. Por&#233;m, desde 2011 foram publicados ensaios cl&#237;nicos bem sucedidos que tiveram como interven&#231;&#227;o exerc&#237;cios baseados em domic&#237;lio e inclu&#237;ram substancialmente mais do que conselhos para &#8220;ir para casa e caminhar&#8221;, solicitando aos pacientes para que estabelecessem metas de exerc&#237;cios e monitorassem suas atividades f&#237;sicas, ocasionando a mudan&#231;a do enfoque. Mesmo com componentes de interven&#231;&#227;o comportamental, o exerc&#237;cio baseado em domic&#237;lio requer menos recursos e menores custos que o exerc&#237;cio supervisionado em esteira, sendo mais acess&#237;veis e provavelmente mais aceit&#225;veis para muitos pacientes, o que poderia favorecer a uma maior ades&#227;o ao tratamento.<sup><xref ref-type="bibr" rid="B13">13</xref></sup></p>
    <p>Na avalia&#231;&#227;o funcional de pacientes com DAO de MMII, o teste de caminhada de seis minutos vem ganhando espa&#231;o, como uma medida validada, mais bem relacionada aos n&#237;veis de atividade f&#237;sica que o teste em esteira, sem estar associado a um efeito de aprendizado quando testes repetidos s&#227;o realizados.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Em pacientes com DAO de MMII, em compara&#231;&#227;o aos testes realizados em esteira, as altera&#231;&#245;es no desempenho observadas na caminhada de seis minutos t&#234;m sido melhor associadas a desfechos como mortalidade e perda de mobilidade.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
    <p>No artigo &#8220;Intensidade de Exerc&#237;cio durante o Teste de Caminhada de 6 Minutos em Pacientes com Doen&#231;a Arterial Perif&#233;rica&#8221;,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> o LA foi alcan&#231;ado no teste de caminhada de 6 minutos em 60% dos indiv&#237;duos. O consumo pico de oxig&#234;nio obtido durante o teste em esteira, assim como o ITB, foram maiores nos pacientes que n&#227;o alcan&#231;aram o LA durante o teste de caminhada de 6 minutos. O teste de caminhada de 6 minutos foi mais dif&#237;cil para mulheres e pacientes com baixa aptid&#227;o cardiorrespirat&#243;ria, revelando maior intensidade relativa de esfor&#231;o de exerc&#237;cio para esses pacientes. Isso &#233; algo relevante na pr&#225;tica, pois visando &#224; melhora da fun&#231;&#227;o cardiovascular, recomenda-se que o treinamento f&#237;sico seja realizado acima do LA.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> Portanto, o artigo mostra que existe fundamenta&#231;&#227;o para a utiliza&#231;&#227;o de caminhada no solo como modo de exerc&#237;cio preferencial principalmente para mulheres e pacientes com baixa aptid&#227;o cardiorrespirat&#243;ria. Para homens e pacientes com maior aptid&#227;o cardiorrespirat&#243;ria devem ser considerados exerc&#237;cios mais intensos, em cicloerg&#244;metros, erg&#244;metros el&#237;pticos ou mesmo esteiras, visando atingir o LA e, consequentemente, melhorar aptid&#227;o f&#237;sica.</p>
    <p>Por fim, vale mais uma vez ressaltar que o artigo &#8220;Exercise Intensity During 6-min Test in Patients with Peripheral Artery Disease&#8221; apresenta originais e interessantes resultados, mas sendo um estudo observacional unic&#234;ntrico, com pequeno n&#250;mero de indiv&#237;duos, obviamente, apresenta limita&#231;&#245;es que impedem fortes conclus&#245;es. Portanto, as importantes informa&#231;&#245;es aplic&#225;veis &#224; pr&#225;tica cl&#237;nica que constam nos resultados do estudo publicado nesse artigo merecem ser consideradas como temas de futuras pesquisas.</p>
  </body>
  <back>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Farah BQ, Ritti-Dias RM, Montgomery P, Cucato GG, Gardner A. Exercise Intensity during 6-Minute Walk Test in Patients with Peripheral Artery Disease. Arq Bras Cardiol. 2020; 114(3):486-492</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farah</surname>
              <given-names>BQ</given-names>
            </name>
            <name>
              <surname>Ritti-Dias</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cucato</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Exercise Intensity during 6-Minute Walk Test in Patients with Peripheral Artery Disease</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>3</issue>
          <fpage>486</fpage>
          <lpage>492</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Neder JA, Nery LE. Teste de Exerc&#237;cio Cardiopulmonar. J Pneumol. 2002; 28(Supl 3): 166-206.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neder</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Nery</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Teste de Exerc&#237;cio Cardiopulmonar</article-title>
          <source>J Pneumol</source>
          <year>2002</year>
          <volume>28</volume>
          <supplement>Supl 3</supplement>
          <fpage>166</fpage>
          <lpage>206</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8): e1020&#8211;e1030.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rudan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fowkes</surname>
              <given-names>FJI</given-names>
            </name>
            <name>
              <surname>Rahimi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fowkes</surname>
              <given-names>FGR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis</article-title>
          <source>Lancet Glob Health</source>
          <year>2019</year>
          <volume>7</volume>
          <issue>8</issue>
          <fpage>e1020</fpage>
          <lpage>e1030</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Beckman JA, Duncan MS, Damrauer SM, Wells QS, Barnett JV, Wasserman DH, et al. Microvascular disease, peripheral artery disease, and amputation. Circulation. 2019;140(6):449&#8211;58.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beckman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Damrauer</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>QS</given-names>
            </name>
            <name>
              <surname>Barnett</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Wasserman</surname>
              <given-names>DH</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Microvascular disease, peripheral artery disease, and amputation</article-title>
          <source>Circulation</source>
          <year>2019</year>
          <volume>140</volume>
          <issue>6</issue>
          <fpage>449</fpage>
          <lpage>458</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, et al. High-sensitivity cardiac troponin and natriuretic peptide with risk of lower extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study. Eur Heart J. 2018;39(25):2412&#8211;9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsushita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kwak</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ballew</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Sang</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>High-sensitivity cardiac troponin and natriuretic peptide with risk of lower extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study</article-title>
          <source>Eur Heart J</source>
          <year>2018</year>
          <volume>39</volume>
          <issue>25</issue>
          <fpage>2412</fpage>
          <lpage>2419</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763&#8211;816.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboyans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ricco</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bartelink</surname>
              <given-names>MEL</given-names>
            </name>
            <name>
              <surname>Bjorck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brodmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cohnert</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
            <collab>ESC Scientific Document Group</collab>
          </person-group>
          <article-title>2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)</article-title>
          <source>Eur Heart J</source>
          <year>2018</year>
          <volume>39</volume>
          <issue>9</issue>
          <fpage>763</fpage>
          <lpage>816</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686-e725.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerhard-Herman</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Gornik</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barshes</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Corriere</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Drachman</surname>
              <given-names>DE</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</article-title>
          <source>Circulation</source>
          <year>2017</year>
          <volume>135</volume>
          <issue>12</issue>
          <fpage>e686</fpage>
          <lpage>e725</lpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. T&#243;th-Vajna Z, T&#243;th-Vajna G, Gombos Z, Szil&#225;gyi B, J&#225;rai Z, Berczeli M, S&#243;tonyi P. Screening of peripheral arterial disease in primary health care. Vascular Health Risk Manag. 2019 Aug 20;15:355-63.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T&#243;th-Vajna</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>T&#243;th-Vajna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gombos</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Szil&#225;gyi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>J&#225;rai</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Berczeli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>S&#243;tonyi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Screening of peripheral arterial disease in primary health care</article-title>
          <source>Vascular Health Risk Manag</source>
          <year>2019</year>
          <month>08</month>
          <day>20</day>
          <volume>15</volume>
          <fpage>355</fpage>
          <lpage>363</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, et al. Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease. Circulation. 2018;137(14):1435-46.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khakharia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Binney</surname>
              <given-names>ZO</given-names>
            </name>
            <name>
              <surname>DeMartino</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Brewster</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Goodney</surname>
              <given-names>PP</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease</article-title>
          <source>Circulation</source>
          <year>2018</year>
          <volume>137</volume>
          <issue>14</issue>
          <fpage>1435</fpage>
          <lpage>1446</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Klaphake S, Buettner S, Ultee KH, van Rijn MJ, Hoeks SE, Verhagen HJ. Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta-analysis. J Cardiovasc Surg (Torino). 2018;59(2):150-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klaphake</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Buettner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ultee</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>van Rijn</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hoeks</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Verhagen</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta-analysis</article-title>
          <source>J Cardiovasc Surg (Torino)</source>
          <year>2018</year>
          <volume>59</volume>
          <issue>2</issue>
          <fpage>150</fpage>
          <lpage>157</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Saratzis A, Paraskevopoulos I, Patel S, Donati T, Biasi L, Diamantopoulos A, et al. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2019;12(12):1125-36.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saratzis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paraskevopoulos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Donati</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Biasi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Diamantopoulos</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials</article-title>
          <source>JACC Cardiovasc Interv</source>
          <year>2019</year>
          <volume>12</volume>
          <issue>12</issue>
          <fpage>1125</fpage>
          <lpage>1136</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Fakhry F, van de Luijtgaarden KM, Bax L, den Hoed PT, Hunink MG, Rouwet EV, Spronk S. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg. 2012;56(4):1132-42.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fakhry</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>van de Luijtgaarden</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>den Hoed</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Hunink</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Rouwet</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Spronk</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Supervised walking therapy in patients with intermittent claudication</article-title>
          <source>J Vasc Surg</source>
          <year>2012</year>
          <volume>56</volume>
          <issue>4</issue>
          <fpage>1132</fpage>
          <lpage>1142</lpage>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. McDermott MM, Polonsky T. Home-based exercise: a therapeutic option for peripheral artery disease. Circulation. 2016; 134(16):1127&#8211;9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Polonsky</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Home-based exercise: a therapeutic option for peripheral artery disease</article-title>
          <source>Circulation</source>
          <year>2016</year>
          <volume>134</volume>
          <issue>16</issue>
          <fpage>1127</fpage>
          <lpage>1129</lpage>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. McDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Ferrucci L. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014; 130(1):61&#8211;8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Guralnik</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kibbe</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ferrucci</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease</article-title>
          <source>Circulation</source>
          <year>2014</year>
          <volume>130</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Temfemo A, Chlif M, Mandengue SH, Lelard T, Choquet D, Ahmaidi S. Is there a beneficial effect difference between age, gender, and different cardiac pathology groups of exercise training at ventilatory threshold in cardiac patients? Cardiol J. 2011;18(6):632-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Temfemo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chlif</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mandengue</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lelard</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Choquet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ahmaidi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Is there a beneficial effect difference between age, gender, and different cardiac pathology groups of exercise training at ventilatory threshold in cardiac patients?</article-title>
          <source>Cardiol J</source>
          <year>2011</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>632</fpage>
          <lpage>638</lpage>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <p>Minieditorial referente ao artigo: Intensidade de Exerc&#237;cio durante o Teste de Caminhada de 6 Minutos em Pacientes com Doen&#231;a Arterial Perif&#233;rica</p>
      </fn>
    </fn-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Exercise and Six-Minute Walk Test in Lower Extremity Occlusive Peripheral Arterial Disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-8817-1255</contrib-id>
          <name>
            <surname>Carvalho</surname>
            <given-names>Tales de</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label>1</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Cl&#237;nica de Preven&#231;&#227;o e Reabilita&#231;&#227;o Cardiosport, Florian&#243;polis, SC &#8211; Brazil</institution>
      </aff>
      <aff id="aff2001">
        <label>2</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade do Estado de Santa Catarina (UDESC-SC), Florian&#243;polis, SC &#8211; Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c01001"> Mailing Address: Tales de Carvalho &#8226; Avenida Jornalista Rubens de Arruda Ramos, 2354, apto 201. Postal Code 88015-705, Florian&#243;polis, SC &#8211; Brazil E-mail: tales@cardiol.br, talescarvalho@icloud.com </corresp>
      </author-notes>
      <kwd-group xml:lang="en">
        <kwd>Peripheral Arterial Disease</kwd>
        <kwd>Intermittent Claudication</kwd>
        <kwd>Anaerobic Threshold</kwd>
        <kwd>Exercise</kwd>
        <kwd>Walk Test</kwd>
        <kwd>Physical Activities of Daily Living</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>The article &#8220;Exercise Intensity During 6-min Test in Patients with Peripheral Artery Disease&#8221;<sup><xref ref-type="bibr" rid="B1">1</xref></sup> provides original, practically useful information to be considered in the diagnosis, prognosis and mainly in the functional assessment that allows a better prescription of physical exercise in the medical treatment of the disease. The study was conducted with the aim of determining whether overground walking would allows the detection of the first ventilatory threshold, also known as anaerobic threshold (AT), in symptomatic patients with lower extremity occlusive peripheral arterial disease (LE-OPAD). AT is a marker of exercise intensity, useful for the determination of the optimal zone for physical training focused on improvement in cardiorespiratory fitness.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
      <p>LE-OPAD is an important public health problem. According to global epidemiology report, the disease affected 202 million individuals in 2010, and 237 million in 2015, with a 22% increase during this period.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> The association of OPAD with major cardiovascular events (MACE) has been well documented; in the severe stage of the disease, with presence of critical ischemia, there is a high risk of cardiovascular events, lower limb amputation and death,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> with association with elevated levels of cardiac troponin and N terminal pro-brain natriuretic peptide (NT-proBNP).<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
      <p>LE-OPAD is highly suspected in the presence of pain in lower limbs when walking, without apparent orthopedic problem, and an ankle brachial index (ABI) lower than 0.90 at rest. Walking tests should be performed to help in the diagnosis, particularly when the ABI is greater than 0.91, and in the functional classification and exercise prescription.<sup><xref ref-type="bibr" rid="B6">6</xref></sup>Field walking tests allow the identification of intermittent claudication, with determination of the distance walked to symptom onset (initial claudication) and to maximum functional limitation (absolute claudication). In treadmill tests, the measurement of the ABI has been proposed, both at rest and after exercise. The presence of the disease is strongly suspected when ABI is reduced by at least 20% and 30mmHg after exercise compared with rest.<sup><xref ref-type="bibr" rid="B7">7</xref></sup> However, resting ABI, which has been widely used in clinical practice, can produce false negative results, which is of particular importance in patients with poorly compressible arteries. In the study by T&#243;th-Vajna et al.,<sup><xref ref-type="bibr" rid="B8">8</xref></sup> almost one fourth of the individuals with a diagnosis had poorly compressible arteries or was considered symptomatic with a negative ABI. Therefore, in case of suspicion of LE-OPAD, a deeper investigation is recommended despite normal ABI values.</p>
      <p>In symptomatic patients, exercise can affect morbidity and mortality, with improvement of symptoms and quality of life and increase of maximum walking distance, and thus must be part of the optimized treatment.<sup><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref></sup> Therefore, all patients with intermittent claudication should receive optimized medical treatment, i.e., a combination of lifestyle changes with pharmacological therapy, considering the body of evidence showing a reduction in cardiovascular events and improvement of the outcomes related to the lower limbs.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
      <p>Physical training has been shown to be safe, and the walking tests with claudication symptom induction considered the best option.<sup><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref></sup> However, when walking tests cannot be performed, other exercises such as cycling, resistance exercise and exercises using an upper extremity ergometer have been shown effective.<sup><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup> It is worth mentioning that patients with critical ischemia cannot perform physical exercises, but should be considered eligible as soon as the interventionist approach is successfully completed.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref></sup></p>
      <p>Many clinical trials have consistently shown that supervised treadmill training improves the gait of patients with LE-OPAD. In a meta-analysis, Fakhry et al.<sup><xref ref-type="bibr" rid="B12">12</xref></sup> evaluated 1,054 patients from 25 studies and concluded this type of exercise training was effective in increasing maximum walking distance (mean increase of 180 meters) and pain-free walking distance (mean increase of 11 meters).<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
      <p>Three randomized clinical trials that evaluated 493 patients with LE-OPAD, showed that home-based exercise programs that included behavior change techniques, improved walking capacity, and higher performance gain on the six-minute walk test compared with supervised treadmill training.<sup><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup>In other words, while supervised treadmill walking programs are superior in the improvement of treadmill walking performance, the home-based programs are superior in improving overground walking, which is more related to daily life activities.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
      <p>Although home-based overground walking programs have been recently shown effective in improving the performance in daily life activities, apart from being more convenient and cheaper compared with supervised treadmill exercise,<sup><xref ref-type="bibr" rid="B14">14</xref></sup>small older studies showed little or no benefit. Therefore, the American College of Cardiology/American Heart Association 2006 Practice Guidelines state that there was no evidence to support the recommendation for the patient &#8220;to go home to walk&#8221;. However, since 2011, successful clinical trials with home-based exercise interventions that included much more than recommendations like &#8220;go home to walk&#8221;, such as the instructions for patients to stablish exercise goals and monitor their exercises, thereby promoting a change of focus. Even adding behavior change techniques, home-based exercises require fewer resources and less cost compared with supervised treadmill exercise, and thus are more accessible and probably more acceptable by many patients, which may ultimately lead to higher treatment compliance.<sup><xref ref-type="bibr" rid="B13">13</xref></sup></p>
      <p>In functional assessment of patients with LE-OPAD, six-minute walk test has gained popularity as a validated measure and better related to physical activity levels compared with the treadmill test, with no association with the learning effect of repeated tests.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> In patients with LE-OPAD, compared with treadmill tests, changes in the performance on six-minute walk test have been more associated with outcomes as mortality and loss of mobility.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
      <p>In the paper &#8220;Exercise Intensity During 6-min Test in Patients with Peripheral Artery Disease&#8221;,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> AT was reached in 60% of patients, and peak oxygen consumption and ABI during treadmill test were higher in the other 40% patients. The six-minute walk test was more difficult for women and patients with low cardiorespiratory fitness, indicating a higher relative intensity of exercise effort for these patients. This is relevant in practice, since it is recommended that exercise training be performed above the AT aiming at improving cardiovascular function.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> Therefore, the study corroborates the use of overground walking as the exercise mode of choice for women and patients with low cardiorespiratory fitness. More intense exercise training should be considered for men and patients with better cardiovascular fitness including cycle and elliptical ergometers, and even treadmills, to reach the AT and consequently improve physical fitness.</p>
      <p>Finally, it is worth pointing out that the article &#8220;Exercise Intensity During 6-min Test in Patients with Peripheral Artery Disease&#8221; provides original and interesting results, but since it is an observational, monocentric study, it has limitations that prevent firm conclusions being drawn. Therefore, the study provides important information that are applicable to clinical practice and should be considered as the subject of future research.</p>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <p>Short Editorial related to the article: Exercise Intensity during 6-Minute Walk Test in Patients with Peripheral Artery Disease</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
